OncoAlly™ Cancer Predisposition
Test Code – OA010
OncoAlly™ Cancer Predisposition uses a whole genome sequencing platform to analyze 87 genes for genetic variants associated with hereditary cancers.
*This is an optional analysis when ordering OncoAlly™ Solid Tumor Analysis.
When to Order
Order this test when a patient has a medical or family history suggestive of one or more hereditary cancer predisposition syndromes or when germline variant analysis for hereditary cancer predisposition is necessary to guide medical management.
- Sequence analysis of hereditary cancer-associated genes (single nucleotide variants, deletions, insertions, and characterized intronic variants)
- Copy number variant analysis of hereditary cancer-associated genes (duplications/deletions, mobile element insertions, and inversions)
81162, 81432, 81433, 81435, 81436, 81479
The CPT codes provided are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
A report will be issued concurrently with the OncoAlly™ Solid Tumor Analysis report, within 14 days from receipt of required samples.